Observation for the efficacy and mechanism of artemether in the treatment of acne vulgaris

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026377

Enrollment

Unknown

Registered

2019-10-05

Start date

2017-12-01

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne

Interventions

Experimental group:Artemether for external use

control group:Retinoic acid cream for external use

Eligibility

Sex/Gender

All

Age

13 Years to 50 Years

Inclusion criteria

Inclusion criteria: Choose 70 patients of grade I and II (8th edition of People's Health Publishing House of Dermatology and Venereology) who meet the clinical diagnostic criteria of acne vulgaris in the dermatology clinic of Zhoupu Hospital, and sign the informed consent to the patients. Aged 13-50 years old male and female.

Exclusion criteria

Exclusion criteria: 1. Lactating or pregnant women; 2. Patients with serious primary diseases such as cardio-cerebrovascular, liver, kidney and hematopoietic system, connective tissue diseases such as lupus erythematosus and psychosis; 3. Occupational acne caused by chemicals or acne caused by drugs.

Design outcomes

Primary

Measure	Time frame
acne;papule;	—

Countries

China

Contacts

Public ContactWentong Shen

Department of Dermatology, Zhouyuan Hospital

ursulashen@sina.com+86 13764492473

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026